HealthTech

OpenAI pharmaceutical partnership Novo Nordisk AI drug discovery healthcare AI digital transformation Novo Nordisk OpenAI alliance AI strategy

Novo Nordisk and OpenAI Join Forces to Reshape Drug Discovery

The Danish pharmaceutical leader is embedding OpenAI's most advanced models across research, manufacturing, and commercial operations in a bid to accelerate its next era of growth.

Tech IconsApr 14, 2026BiotechnologyDrug DiscoveryHealthTech

Woman wearing a Whoop fitness tracker during an ice bath recovery session as Whoop launches its women’s health biomarker panel, integrating wearable data with women’s health biomarkers.

Whoop Launches Women’s Biomarker Panel as Femtech Surges

The Boston wearable pioneer's new blood biomarker panel targets female physiology, reflecting a broader industry shift where women's health has become both a scientific priority and a growth engine.

Tech IconsMar 13, 2026Digital HealthFemtechWearable Technology

Eli Lilly headquarters as weight-loss drugs Mounjaro and Zepbound drive record quarterly revenue

Lilly Delivers Record Q4 as Weight-Loss Drugs Rewrite Economics

The Indianapolis drugmaker posted $19.3 billion in Q4 revenue as tirzepatide therapies cement metabolic disease dominance and fuel 2026 guidance.

Tech IconsFeb 4, 2026BiotechEarnings SeasonPharmaceuticals

The Strava app displayed on a smartphone, highlighting the platform’s activity tracking and social features ahead of its planned IPO.

Strava Files for IPO at $2.2B Valuation, $500M Revenue

The fitness tracking platform confidentially submitted SEC paperwork with Goldman Sachs leading the offering, positioning for a potential Q1 2026 debut as subscription growth accelerates.

Tech IconsJan 9, 2026Consumer TechnologyPublic MarketsSubscription Economy

Becky Quick, CNBC journalist and host, photographed in a studio setting ahead of the CNBC Cures Summit on rare disease research, Becky Quick brings rare disease innovation into focus through CNBC Cures, uniting science, patients and policy to accelerate genetic research.

Becky Quick and CNBC Cures: Advancing Rare Disease Innovation

Read more

President Donald Trump meets pharmaceutical executives at the White House as Medicare pricing reforms set the stage for oral Wegovy’s FDA approval.

Trump Administration Medicare Deal Powers Novo's Oral Rollout

Read more

Novartis global headquarters as the company announces a $1.7 billion AI drug discovery partnership with Relation Therapeutics.

Novartis Commits $1.7 Billion to AI-Driven Drug Discovery

Read more

Novo Nordisk’s public-facing operations now sit at the center of investor scrutiny as patent timelines tighten.

Novo Nordisk Meets a Patent Cliff as GLP-1 Dominance Weakens

Read more

Eli Lilly HQ, as it becomes the first trillion-dollar pharma company as GLP-1 therapies reshape global healthcare, competition, and long-term industry value.

Eli Lilly First Pharmaceutical Company to Reach $1T Valuation

Read more

President Donald Trump (L) and Health and Human Services Secretary Robert F. Kennedy Jr. (R) look on as Food and Drug Administration Commissioner Dr. Marty Makary (C) delivers remarks during an announcement by President Donald Trump on “significant medical and scientific findings for America’s children” in the Roosevelt Room of the White House on September 22, 2025 in Washington, DC

FDA Approves Leucovorin in Autism Speech Breakthrough

Read more

Hotel fitness center featuring Peloton equipment under Precor integration

Peloton Raises Prices, Launches AI Fitness Platform Globally

Read more

Robotic-assisted surgical system in operation, highlighting AI integration in clinical practice.

Artificial Intelligence Reshapes Healthcare Amid Worker Shortages

Read more

AI Cyberattacks Surge as Deepfakes and ML Breach Defenses

Workday Reports Data Breach Through Third-Party CRM System

Security Flaw in Perplexity's Comet AI Browser Exposes User Data

DDoS Attacks Overwhelm Global Digital Networks via IoT Botnets

AI Tools Turn Hackers Into Sophisticated Cybercrime Threat

OpenAI $852B valuation Sam Altman investor concerns enterprise pivot growth valuation secondary market discounts OpenAI valuation scrutiny

OpenAI's $852 Billion Price Tag Unnerves Its Own Backers

Read more

CoreWeave AI infrastructure Meta deal AI compute GPU cloud growth hyperscale data center infrastructure CoreWeave AI deals expansion

CoreWeave Locks In Meta and Anthropic in Back-to-Back Deals

Read more

Scott Bessent Trump Accounts program US Treasury as Trump Accounts savings system launches with BNY Mellon and Robinhood for newborn savings accounts policy and public private capital model

BNY Mellon and Robinhood to Power Trump Accounts Program

Read more